| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Monoamine transport 0.9420677361853848 4.073386255284742 4.633448547730623e-05 0.027823936272093 0.0007235308116841 2 O15127 1 |
| Drug induction of bile acid pathway 0.9123588829471214 3.9358575003402967 8.290015492318226e-05 0.0492349351962987 0.001131118686288 2 P08183 1 |
| Familial hyperlipidemia type 2 0.8969102792632231 3.863391997243093 0.0001118233458647 0.0658368951357821 0.0014804438615578 2 P01130 1 |
| Familial hyperlipidemia type 3 0.9569513989989746 3.5705000727079 0.0003563003554272 0.1950906220675985 0.0036164486075862 3 Q8WTV0 1 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.7140746359792044 3.3158067465210266 0.0009137899530191 0.4269329180002437 0.0079499725912667 24 Q14739,O75845,P35610,Q16850,Q9UBM7,P48449,P37268,Q14534,Q9BWD1,Q15392,O95864,O00767 12 |
| Matrix metalloproteinases 0.7825311942959063 3.305054417111024 0.0009495796121878 0.4392996916140267 0.0081449856876397 2 Q9UGU0 1 |
| Metabolic pathway of ldl hdl and tg including diseases 0.867161961367014 3.175442519245522 0.0014960815850393 0.5981980269258527 0.0124810093875199 3 Q8WTV0,P01130 2 |
| Sarscov2 b117 variant antagonises innate immune activation 0.754604872251935 3.162454980460662 0.0015644492329185 0.6146085181018461 0.0128749943628025 2 O94826 1 |
| Arachidonate epoxygenase epoxide hydrolase 0.6999405822935303 2.8755542246797483 0.0040331886350704 0.914665668004945 0.0266979552038899 2 P34913 1 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.7958395245170885 2.8468104045925675 0.0044159654029496 0.932476422667648 0.0283086624252245 3 Q9UPY5,P08195 2 |
| Sars coronavirus and innate immunity 0.6779560308972141 2.757149231588356 0.0058307734183356 0.9715990816007484 0.0348131471741802 2 Q7Z434 1 |
| Sarscov2 and covid19 pathway 0.8637503095396831 2.699262845918889 0.0069493265733697 0.9856916733663024 0.0393361760724398 4 Q8WTV0,P35610 2 |
| Steroid biosynthesis 0.6672608437314389 2.6989010003722993 0.0069568868253595 0.9857578593843288 0.0393361760724398 2 Q99829 1 |
| Ketogenesis and ketolysis 0.9266736322601964 2.697993818958714 0.0069758735892011 0.985922733901744 0.0393361760724398 6 O43772,P35610 2 |
| Cholesterol biosynthesis with skeletal dysplasias 0.919151140206134 2.6677464685233816 0.0076361857253013 0.9906116321556212 0.0422767009700774 6 Q14739,Q15392,Q9UBM7,Q16850 4 |
| Hematopoietic stem cell gene regulation by gabp alphabeta complex 0.8515531967426253 2.647080773319469 0.0081189957740481 0.9930196051477372 0.0441470395213869 4 Q07820,Q15554 2 |
| Statin inhibition of cholesterol production 0.8831855957959386 2.63908927807768 0.0083129085616588 0.9938031920469548 0.0448014275579669 7 Q8WTV0,P35610,P37268,Q14534,P01130 5 |
| Proximal tubule transport 0.7882417741660548 2.6360588579501174 0.0083875181470465 0.9940807220698294 0.0448070048381696 11 P04920,P08183,P11166,P08195 4 |
| Amino acid metabolism pathway excerpt histidine catabolism extension 0.6259655377302523 2.4699502664441875 0.0135131837637898 0.9997478883551628 0.0633040685549847 2 P00367 1 |
| Male infertility 0.5897148652073351 2.3602757803452348 0.0182613538415026 0.9999866495658032 0.0783180597850359 22 Q15165,P08183,Q01831 3 |
| Glial cell differentiation 0.5950683303624578 2.29438030743054 0.0217686632994786 0.9999984902095052 0.0895751077660981 2 P26038 1 |
| Type i interferon induction and signaling during sarscov2 infection 0.6781575037147113 2.273227563314679 0.0230124700967877 0.9999993043136504 0.0928118827082366 3 P19525,Q7Z434 2 |
| Cholesterol biosynthesis pathway 0.6567964568995994 2.2220558834138915 0.0262795291965778 0.9999999095332596 0.1012926157007335 14 Q16850,P48449,Q9UBM7,P37268,O75845 5 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.6999832438721048 2.201834293683812 0.0276770156934964 0.9999999622752694 0.1049053236393168 11 P37268,P35610 2 |
| Adipogenesis 0.6630269412630959 2.1715543885902404 0.0298892905411929 0.9999999905773932 0.1100411359960461 13 O75844,Q16822 2 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.6278200857412956 2.148913694452063 0.0316412420461515 0.9999999968660116 0.1141343475512849 15 O75844,P42167,P50402,Q9Y2U8,O60725 5 |
| Lung fibrosis 0.7714552487350593 2.0508521015181316 0.0402813518978439 0.9999999999866448 0.1383192814926054 6 P09601 1 |
| Pkcgamma calcium signaling pathway in ataxia 0.6329866270430916 2.042327613632778 0.0411190447489506 0.999999999992153 0.1398966382799495 3 P23634,Q15118 2 |
| Overview of interferonsmediated signaling pathway 0.5499108734402967 2.031200572288309 0.0422346523686059 0.999999999996138 0.1425343529129853 2 P42224 1 |
| Notch signaling 0.7172767271281786 2.022378389674506 0.0431372758534411 0.9999999999978252 0.143789118925373 8 P78536 1 |
| 7oxoc and 7betahc pathways 0.7131146260658682 2.0028819196236585 0.0451899641925837 0.999999999999412 0.1479606892112014 8 Q9UBM7 1 |
| Oxidation by cytochrome p450 0.75776700251664 1.9914774140298537 0.0464284258839371 0.9999999999997332 0.1496027056260196 6 Q6UW02,O43169,Q16850 3 |
| Fatty acid betaoxidation 0.5442018049679355 1.9341161243688765 0.0530988518439956 0.9999999999999964 0.1606231478516316 20 P35610 1 |
| Kennedy pathway from sphingolipids 0.761072968723852 1.9146449270444996 0.0555378014531315 0.9999999999999992 0.1617957932748295 5 Q9BVG9,Q9UG56 2 |
| Copper homeostasis 0.7343880405928095 1.8892491844081616 0.0588584470671094 1.0 0.1674990386162132 6 P78536 1 |
| Oxysterols derived from cholesterol 0.7267166327574879 1.855486430928984 0.063526795130095 1.0 0.17661240062812 6 Q9UBM7 1 |
| Omega3 omega6 fatty acid synthesis 0.7149889888213732 1.803670820669392 0.0712829264899541 1.0 0.1879277152916973 6 O95864,O15254 2 |
| Nad metabolism 0.510992275698171 1.798360654613702 0.0721198735558532 1.0 0.188513531399648 2 P09874 1 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.6536860879904796 1.7531885846753934 0.0795696418100329 1.0 0.1985979994356968 4 O60725,P02545,Q03252 3 |
| Nipbl role in dna damage cornelia de lange syndrome 0.6502676525179667 1.737000019527527 0.0823871674230998 1.0 0.2015011444203525 4 Q14676,Q6KC79 2 |
| Hair follicle development organogenesis part 2 of 3 0.6490547623374789 1.7312509575139523 0.0834070143251697 1.0 0.2031794868961134 4 P13591,Q9BZE4 2 |
| Triacylglyceride synthesis 0.6417941659705318 1.6967798837738413 0.0897382832705844 1.0 0.2114620935104227 4 Q9NUQ2,O00116 2 |
| Gastric cancer network 2 0.5475722690036037 1.6830620668319316 0.0923630768106107 1.0 0.213874957329513 15 Q14739,Q8WVB6,P40938,P11388,Q8TDN6,Q8WYP5 6 |
| Interactome of polycomb repressive complex 2 prc2 0.6750061679208823 1.6253199394754096 0.1040944049545598 1.0 0.231363111742069 6 Q9Y2W1,Q15022,P55199,Q9NYF8 4 |
| Hair follicle development cytodifferentiation part 3 of 3 0.6904538883153176 1.6112215914124242 0.1071314333943693 1.0 0.2361474661124906 5 P78536,Q9BZE4 2 |
| Smc1smc3 role in dna damage cornelia de lange syndrome 0.6473973573050001 1.5908293057656866 0.1116479957537688 1.0 0.2424971845919148 7 O60934,O60216,Q9UQE7,Q14676,Q14683 5 |
| Development of ureteric collection system 0.6734527067451137 1.537115827567173 0.1242649477265058 1.0 0.2618593535136404 5 O94813,Q9Y6N7,Q13418 3 |
| Notch signaling pathway 0.4936288506870072 1.4625818247810611 0.1435818395371535 1.0 0.293427316369552 17 O00459,P49768,P78536 3 |
| Ferroptosis 0.4286220523628609 1.4451240236792229 0.1484230521554848 1.0 0.3012987958756341 26 P16435,P04035,P08195,Q9UPY5,Q15758,P37268,P02792,P09601,Q9Y277,Q96QD8,Q16881 11 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.6506167086023773 1.4370858774290982 0.1506935935382245 1.0 0.3038821141217839 5 P07099,P09601 2 |
| Glycerolipids and glycerophospholipids 0.6288598528705439 1.4167925294231938 0.1565435945200954 1.0 0.3146371256195978 6 Q86UL3,Q9UG56 2 |
| Sterol regulatory elementbinding proteins srebp signaling 0.4021231873024943 1.3828179053486938 0.1667207073565879 1.0 0.3192858829564844 31 Q8WTV0,Q16850,P48449,P37268,Q96JM3,Q14534,P01130,O00767 8 |
| Glycerophospholipid biosynthetic pathway 0.5704144269881055 1.3151122884537747 0.1884721672757621 1.0 0.3484873446417029 8 Q8WUK0 1 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.5995377675057615 1.2833544646807618 0.199367919255613 1.0 0.3606798449824686 6 P09601 1 |
| Vitamin b12 metabolism 0.5632173767353619 1.2797750681546096 0.2006242546713292 1.0 0.3614797961385785 8 Q8WTV0 1 |
| Effect of progerin on genes involved in hutchinsongilford progeria syndrome 0.4999221574035653 1.2655892484469573 0.2056601773333439 1.0 0.3651517434285903 13 P45973,O60341,O94776,Q14839,P83916 5 |
| Omega9 fatty acid synthesis 0.592823942732963 1.252759386591103 0.2102932861499957 1.0 0.372292474608568 6 O95864 1 |
| Metapathway biotransformation phase i and ii 0.4234390603995595 1.2257220681403196 0.2203032827126967 1.0 0.3824838855012881 22 Q6UW02,Q8NCH0,Q16850,Q7LGA3,P07099 5 |
| P53 transcriptional gene network 0.5110654468070174 1.2090878986632 0.2266290778505788 1.0 0.387688506772479 11 Q01831,P11166 2 |
| Ppar signaling pathway 0.4558738183473294 1.1898759144057605 0.2340951663728205 1.0 0.397114084459743 16 Q13418,O15254,Q16822,O00767,P50416,O95864 6 |
| Preimplantation embryo 0.5599512481686011 1.1789860027733206 0.2384037495141737 1.0 0.3983272886366519 7 P51532,Q92945,Q99729,Q9P0M6 4 |
| Mitochondrial long chain fatty acid betaoxidation 0.4740599230423861 1.1782819688201125 0.2386842137465827 1.0 0.3983272886366519 14 O43772,P50416 2 |
| Joubert syndrome 0.4295908190789193 1.1328393998565982 0.2572817023855021 1.0 0.4246193949939587 19 Q15382,Q15154,P49959,Q10713,O75695,P61006,Q8TD19,P09874,Q92878,Q9UM54,Q8WXW3,P21333,Q9Y4I1 13 |
| Arrhythmogenic right ventricular cardiomyopathy 0.4317615468311382 1.108681178066182 0.2675677443891497 1.0 0.4345300168879792 18 P02545,Q99959,P50402,Q02487,Q14118,Q14126,P14923 7 |
| Krebs cycle disorders 0.5594548877048034 1.1008448055531277 0.2709642074540679 1.0 0.4367543109213357 6 P53597,O00330,Q9P2R7,P07954 4 |
| Nrf2are regulation 0.4959370309314639 1.0775559549712104 0.2812319670977836 1.0 0.4507112314803953 10 P09601 1 |
| Nuclear receptors metapathway 0.3212153291782891 1.0731025817805488 0.2832250927544097 1.0 0.4527141246389384 54 P27105,P08183,P11166,O15439,Q9UPY5,P02792,P09601,P50416 8 |
| Aspirin and mirnas 0.4490418105617497 1.0546020095386046 0.2916073843456965 1.0 0.4620417031559002 3 O15439 1 |
| Tryptophan metabolism 0.4511239106493514 1.0447315795952692 0.2961470450925612 1.0 0.4660298461534102 14 P35610 1 |
| Proteoglycan biosynthesis 0.5049108972732201 1.0363348735161568 0.3000459420747248 1.0 0.4697377345077311 4 Q8NCH0 1 |
| Endoplasmic reticulum stress response in coronavirus infection 0.4863909100499523 0.8354822635637763 0.403446229176122 1.0 0.5740625083370522 7 Q12972 1 |
| Zinc homeostasis 0.3484848484848584 0.7970901190245634 0.4253986945323382 1.0 0.5914790067812649 2 Q15043 1 |
| Orexin receptor pathway 0.3684149835735671 0.7717897752036477 0.4402389486015834 1.0 0.6082524949910626 20 Q8TDW0,P11166,Q00059,P01130,P50336,O00459 6 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.4707048835335628 0.7642871142720126 0.4446961626037915 1.0 0.6082524949910626 7 P09601 1 |
| Dna damage response only atm dependent 0.3622309331066338 0.7325128092181569 0.4638556273593579 1.0 0.6263593726426807 20 Q16822,P01130 2 |
| Mitochondrial complex iii assembly 0.4275921498743154 0.7282775597719147 0.4664436961668201 1.0 0.6284606437291891 10 P22695,O14949,P31930,Q6DKK2,Q9BRT2 5 |
| Ccl18 signaling pathway 0.4158271496315815 0.7073837559072793 0.4793280288559185 1.0 0.6357418993611097 11 P11166,P07196,P08670,Q96GC9,P42224,P27144 6 |
| Tumor suppressor activity of smarcb1 0.3816021405186489 0.6985078527415391 0.4848596486349164 1.0 0.6386401686047277 15 P51532,Q92922,Q8TAQ2,Q96GM5,Q15022,Q09028 6 |
| Mitochondrial complex i assembly model oxphos system 0.3211819700026729 0.6934970722500706 0.4879976625345497 1.0 0.6386401686047277 28 O43674,O43678,P03886,Q9NPL8,O75380,P49821,Q96CU9,O95299,Q9NX14 9 |
| Mevalonate pathway 0.4675389608598049 0.6931547951926358 0.4882124134316332 1.0 0.6386401686047277 6 Q9BWD1 1 |
| Selenium micronutrient network 0.3999377548953664 0.6660137579751687 0.5054023066208893 1.0 0.6483457358215687 12 Q8WTV0 1 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3590482833162374 0.6563157731260869 0.5116209708804889 1.0 0.6520225206751072 18 Q14739,Q9Y2U8,Q9BTV4,P42167 4 |
| Hedgehog signaling pathway wp47 0.372659732540864 0.6517623469628211 0.5145544952582668 1.0 0.6542039407354582 3 Q96ST3,O00422 2 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.3755911418351398 0.6208273057998959 0.5347132550653289 1.0 0.6742036694301973 14 P11166 1 |
| Osx and mirnas in tooth development 0.3122400475341744 0.586907530248936 0.5572658121106899 1.0 0.6954403269987913 2 Q04721 1 |
| H19 action rbe2f1 signaling and cdkbetacatenin activity 0.4403759203300674 0.5801132957690659 0.56183821818539 1.0 0.6994221730217262 6 Q16527,O75367 2 |
| Ddx1 as a regulatory component of the drosha microprocessor 0.4469078943349527 0.5633003884359122 0.5732303536676462 1.0 0.7081080839423864 5 Q8WYQ5,O60934,P49959 3 |
| Srebf and mir33 in cholesterol and lipid homeostasis 0.4298892188327942 0.5380039167120335 0.590574344575836 1.0 0.7222083852343055 6 O00767,P01130 2 |
| Photodynamic therapyinduced hif1 survival signaling 0.3665408211933928 0.5015948287846183 0.6159525577097205 1.0 0.7442760072325789 12 P11166 1 |
| Disruption of postsynaptic signaling by cnv 0.3835527789696588 0.4920458273307252 0.6226869471827705 1.0 0.7509234669986282 9 Q12959,Q07157 2 |
| 1q211 copy number variation syndrome 0.3736552687322502 0.4750426007785032 0.6347566092563728 1.0 0.7615472981132355 10 Q9NPH0,Q07157 2 |
| Pathways of nucleic acid metabolism and innate immune sensing 0.4171164829117455 0.451263627088883 0.6517995565497388 1.0 0.7737737425707425 5 Q9Y3Z3 1 |
| Endothelin pathways 0.368706909452499 0.4293007382291638 0.6677043796625686 1.0 0.7865221802988477 9 P63096 1 |
| Folate metabolism 0.3366288219027055 0.4248223811685224 0.6709661608668702 1.0 0.7888385945326718 14 Q8WTV0 1 |
| 15q112 copy number variation syndrome 0.3596772157359468 0.390208937921508 0.696382052956092 1.0 0.812445728448774 4 Q06787 1 |
| Valproic acid pathway 0.3820941244930442 0.3606153869678427 0.7183869851380567 1.0 0.8333289027601458 6 P55084,Q99714,P26440,P40939 4 |
| Amyotrophic lateral sclerosis als 0.3341759217490896 0.334549986710537 0.737964577614493 1.0 0.8443968778247473 11 Q9BUN8,P07196,O96008 3 |
| Hedgehog signaling pathway wp4249 0.372992266508027 0.3301206192583456 0.7413088238579646 1.0 0.8443968778247473 6 Q13618,P17252,P17612,Q6IQ16,P48729 5 |
| Pathways affected in adenoid cystic carcinoma 0.2982541334769978 0.3291899958536074 0.7420120840876363 1.0 0.8443968778247473 18 P46100,Q96T88,Q6ZRS2,O95696,Q8IWI9,Q14683 6 |
| Complement and coagulation cascades 0.2611408199643605 0.3280762692440236 0.7428539962683964 1.0 0.8443968778247473 2 P49257 1 |
| Prion disease pathway 0.342714663971605 0.3276448920702574 0.7431801748999418 1.0 0.8443968778247473 9 O14647 1 |
| Thermogenesis 0.2647707787511613 0.3229178626378746 0.7467574479984385 1.0 0.8468813516406871 29 Q15382,O43772,P51532,Q8TAQ2,O60488,Q96GM5,P50416 7 |
| Fbxl10 enhancement of maperk signaling in diffuse large bcell lymphoma 0.3451457446480894 0.300284025980645 0.763960516758214 1.0 0.8615776938995413 8 Q15022,Q9P0M6,O75367 3 |
| Rett syndrome causing genes 0.3009485397104565 0.2944597792811396 0.7684065931779189 1.0 0.8649900466642377 15 P51532,P51608,Q14839,Q14683 4 |
| Tca cycle aka krebs or citric acid cycle 0.2941974004000345 0.2870313168564797 0.7740883412890185 1.0 0.8665805144209784 16 P53597,P31040,P07954,P50213,P09622,O43837,Q99798,Q9P2R7,P40926,P36957 10 |
| Wnt signaling pathway and pluripotency 0.2856613839841819 0.2518743149531554 0.8011382133597746 1.0 0.8903160071826692 16 Q9H0H5,P01130 2 |
| G protein signaling pathways 0.2835318294265529 0.243438782870183 0.8076655028771897 1.0 0.8959349567435493 16 Q02952,P08754,Q92667,Q14344,Q9UBI6,P63096 6 |
| Nanomaterial induced apoptosis 0.32419684958621 0.2333044705802673 0.8155249873657642 1.0 0.9030085769195462 8 O95831 1 |
| Oxidative phosphorylation 0.2444888795459421 0.2308368530603576 0.8174415496985177 1.0 0.9034880286141512 33 Q16795,O43674,O75947,O43678,P03886,O75787,P56134,O75380,P49821,O95299,O00483 11 |
| Ectoderm differentiation 0.2552006720064834 0.2080307665691856 0.8352049445834655 1.0 0.9104803559196016 23 O15439,P35240,P51608 3 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.3135299121535654 0.2025708756300363 0.8394704558943575 1.0 0.9126312405980992 8 Q8WVM7,Q12834,Q14683 3 |
| Mitochondrial gene expression 0.3210963629431447 0.20088603856716 0.840787684791023 1.0 0.9126312405980992 7 Q8WVM0,Q00059,P51610 3 |
| Urea cycle and metabolism of amino groups 0.3168084254941665 0.1897369083554848 0.8495152974354412 1.0 0.9126312405980992 7 P32322,P78540,P00367 3 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.2769031710776159 0.1577025602213723 0.8746911829766271 1.0 0.929645602849504 12 Q9UIW2,O14786,O14647 3 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.2822125576868544 0.1512228975837324 0.8797998883436526 1.0 0.9334462229987536 10 P35240 1 |
| Endochondral ossification 0.2948277385752612 0.1384471023884591 0.8898870730871173 1.0 0.940292460028232 7 P42224,Q96QD8,Q9Y376 3 |
| Endochondral ossification with skeletal dysplasias 0.2948277385752612 0.1384471023884591 0.8898870730871173 1.0 0.940292460028232 7 P42224,Q96QD8,Q9Y376 3 |
| Striated muscle contraction pathway 0.3065715135295923 0.1371849001012005 0.8908846460366007 1.0 0.940292460028232 5 P11532,P06753,P08670,O43707 4 |
| Mrna processing 0.2088892016809172 0.119100514323577 0.9051957232735786 1.0 0.9520970560856812 102 Q14103,O95319,O75494,Q14562,Q8IYB3,O94992,Q13243,Q96DI7,Q86U42,P55769,Q00839,P22626,Q14498,O43395,P67809,O95400,O00267,Q9H0D6,Q15428,Q07955,P09651,Q8WXA9,P08621,Q96SB4,Q99729,P07910,P23246,O75400,Q13242,O43390,O60508,Q15427,P62995,P14866,Q08211,P24928,Q15233,Q6P2Q9,Q16629,P62304,Q13247,Q14683,Q13523 43 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.2530335512631624 0.1076026311831182 0.9143109097299482 1.0 0.9575234809278323 13 P50454,Q32P28,P13674,P07237,Q9NVV0,O75718 6 |
| Epithelial to mesenchymal transition in colorectal cancer 0.2329149456209087 0.1066436340452939 0.9150717009852192 1.0 0.9575234809278323 21 O00459,Q99959 2 |
| Eukaryotic transcription initiation 0.2377399926579466 0.1005162656017279 0.919934470152388 1.0 0.9593152265801442 17 Q9H9Y6,Q9GZS1,P52434,P19387,Q13418,P24928,P32780 7 |
| Head and neck squamous cell carcinoma 0.2302168263643017 0.0853214150686581 0.9320058668466872 1.0 0.9680200424600758 18 O00459 1 |
| Complement system 0.2450920932690557 0.0840074391196808 0.9330505171166904 1.0 0.9680200424600758 12 P07942 1 |
| Gastric cancer network 1 0.2399787691805564 0.0747533335513604 0.9404109723044096 1.0 0.970695393446416 12 Q9ULW0,P11388,Q96Q89 3 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.2381661208693029 0.0621234475375067 0.9504645246243916 1.0 0.9728283957920242 9 Q8IXH7,Q9H3P2,Q92769,O94992,Q13547,O00267,Q04206,Q8WX92 8 |
| Thiamine metabolic pathways 0.2524531668153483 0.0591881676719037 0.9528022339505458 1.0 0.9735848330132254 5 P08559,Q02218,Q9HC21,P29401 4 |
| Ras signaling 0.2008589059437922 0.0492954207193853 0.9606838688196456 1.0 0.9750941268519404 27 O00459,Q9UBI6,P11233,O96013 4 |
| Wntbetacatenin signaling pathway in leukemia 0.2116740260131772 0.0471800711955676 0.9623697107140275 1.0 0.9751799564473258 4 P14923 1 |
| Genes controlling nephrogenesis 0.2181818890427625 0.0366613741449462 0.9707550068917664 1.0 0.9787910582733208 8 O94813,Q13418 2 |
| Splicing factor nova regulated synaptic proteins 0.2034545751184942 0.0343215468519003 0.9726207430868868 1.0 0.9790512934544032 18 O14936,O43491,Q06481 3 |
| Photodynamic therapyinduced unfolded protein response 0.1905896366885016 0.0192816851347912 0.9846163943587484 1.0 0.9878605999414792 10 Q13217,O43776,P05198,P14625,P27797,P08243,Q9UBS4,Q9BY44,Q15084 9 |
|
|
